BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4131112)

  • 1. Herpesvirus type 2-induced, tumor-specific antigen in cervical carcinoma.
    Aurelian L; Davis HJ; Julian CG
    Am J Epidemiol; 1973 Jul; 98(1):1-9. PubMed ID: 4131112
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of herpes simplex virus tumor-associated antigen in uterine cervical cancer tissue: five case studies.
    Notter MF; Docherty JJ; Mortel R; Hollinshead AC
    Gynecol Oncol; 1978 Dec; 6(6):574-81. PubMed ID: 220150
    [No Abstract]   [Full Text] [Related]  

  • 3. Virions and antigens of herpes virus type 2 in cervical carcinoma.
    Aurelian L
    Cancer Res; 1973 Jun; 33(6):1539-47. PubMed ID: 4352393
    [No Abstract]   [Full Text] [Related]  

  • 4. Herpes simplex virus II antigen in adenocarcinoma of the uterine cervix.
    Bhatia A; Ashokraj G
    Indian J Pathol Microbiol; 1988 Apr; 31(2):40-4. PubMed ID: 2844663
    [No Abstract]   [Full Text] [Related]  

  • 5. Herpesvirus antibody and carcinoma in situ of the cervix.
    Catalano LW; Johnson LD
    JAMA; 1971 Jul; 217(4):447-50. PubMed ID: 4326405
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutralization, immunofluorescence and complement fixation tests in identification of antibody to a herpesvirus type 2-induced, tumor-specific antigen in sera from squamous cervical carcinoma.
    Aurelian L; Strandberg JD; Marcus RL
    Prog Exp Tumor Res; 1974; 19():165-81. PubMed ID: 4612606
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls.
    Feorino PM; Palmer EL
    J Infect Dis; 1973 Jun; 127(6):732-5. PubMed ID: 4350521
    [No Abstract]   [Full Text] [Related]  

  • 8. HSV 2-associated antigens in human cervical tissues before and after grafting in nude mice.
    Christenson B; Furgyik S
    Acta Obstet Gynecol Scand; 1983; 62(5):461-6. PubMed ID: 6320579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
    Xu ZH
    Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
    [No Abstract]   [Full Text] [Related]  

  • 10. Summary of informal discussion of part II of genital herpesvirus.
    Nahmias AJ
    Cancer Res; 1973 Jun; 33(6):1483-4. PubMed ID: 4124114
    [No Abstract]   [Full Text] [Related]  

  • 11. A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in Czechoslovakia.
    Janda Z; Kanka J; Vonka V; Svoboda B
    Int J Cancer; 1973 Nov; 12(3):626-30. PubMed ID: 4364794
    [No Abstract]   [Full Text] [Related]  

  • 12. Herpesvirus antigens as markers for cervical cancer.
    Gupta PK; Aurelian L; Frost JK; Carpenter JM; Klacsmann KT; Rosenshein NB; Tyrer HW
    Gynecol Oncol; 1981 Oct; 12(2 Pt 2):S232-58. PubMed ID: 6273263
    [No Abstract]   [Full Text] [Related]  

  • 13. Further studies on an immunoenzymatic assay for herpes simplex virus tumor-associated antigen.
    Tarro G; Flaminio G; Maturo S; Esposito C; Cocchiara R
    Clin Immunol Immunopathol; 1982 Oct; 25(1):126-32. PubMed ID: 6295672
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
    Aurelian L
    Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative diagnostic aspects of herpes simplex virus tumor-associated antigens.
    Notter MF; Docherty JJ
    J Natl Cancer Inst; 1976 Sep; 57(3):483-8. PubMed ID: 185398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of HSV-2-induced early antigen with antibodies from cervical carcinoma patients].
    Jiang JW
    Zhonghua Fu Chan Ke Za Zhi; 1986 Mar; 21(2):107-9, 126. PubMed ID: 3017644
    [No Abstract]   [Full Text] [Related]  

  • 17. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
    McDonald AD; Williams MC; Manfreda J; West R
    Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
    [No Abstract]   [Full Text] [Related]  

  • 18. Variations of cytotoxic antibodies to cells with herpes simplex virus antigens in women with progressing or regressing cancerous lesions of the cervix.
    Thiry L; Sprecher-Goldberger S; Fassin Y; Gould I; Gompel C; Pestiau J; De Halleux F
    Am J Epidemiol; 1974 Oct; 100(4):251-61. PubMed ID: 4370721
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunofluorescence study of the presence of herpes type 1 and type 2 antigens in patients with cancer of the uterine cervix.
    Athanasiu P; Nastac E; Stoian M; Predescu E; Hozoc M
    Virologie; 1978; 29(4):251-3. PubMed ID: 219590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genital herpes and cervical cancer].
    Posevaia TA; Barinskiĭ IF
    Vopr Virusol; 1983; 28(5):518-30. PubMed ID: 6197814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.